Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

New drug cocktail aims to reset gulf war illness symptoms

NCT ID NCT04254627

First seen Jun 19, 2026 · Last updated Jun 19, 2026

Summary

This early-stage study tested a combination of two drugs (etanercept and mifepristone) in 20 male veterans with Gulf War Illness. The goal was to see if the treatment is safe and can help reset the body's systems to reduce symptoms like fatigue, pain, and memory problems. Results will guide future larger studies.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for GULF WAR ILLNESS are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Locations

  • Miami VA Healthcare System

    Miami, Florida, 33125, United States

  • Nova Southeastern University

    Davie, Florida, 33314, United States

Conditions

The condition(s) this trial relates to.

persian gulf syndrome

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.